Ultratard

Country: European Union

Language: Latvian

Source: EMA (European Medicines Agency)

Public Assessment Report Public Assessment Report (PAR)
15-02-2008

Active ingredient:

cilvēka insulīns

Available from:

Novo Nordisk A/S

ATC code:

A10AE01

INN (International Name):

insulin human (rDNA)

Therapeutic group:

Cukura diabēts

Therapeutic area:

Cukura diabēts

Therapeutic indications:

Cukura diabēta ārstēšana.

Authorization status:

Atsaukts

Authorization date:

2002-10-07

Similar products

Active ingredient cilvēka insulīns

cilvēka insulīns

ATC code A10AE01

A10AE01

Marketed by Novo Nordisk A/S

Novo Nordisk A/S

INN (International Name) insulin human (rDNA)

insulin human (rDNA)

Documents in other languages

Patient Information leaflet Patient Information leaflet Spanish 15-02-2008
Summary of Product characteristics Summary of Product characteristics Spanish 15-02-2008
Public Assessment Report Public Assessment Report Spanish 15-02-2008
Public Assessment Report Public Assessment Report Czech 15-02-2008
Patient Information leaflet Patient Information leaflet Danish 15-02-2008
Summary of Product characteristics Summary of Product characteristics Danish 15-02-2008
Public Assessment Report Public Assessment Report Danish 15-02-2008
Patient Information leaflet Patient Information leaflet German 15-02-2008
Summary of Product characteristics Summary of Product characteristics German 15-02-2008
Public Assessment Report Public Assessment Report German 15-02-2008
Public Assessment Report Public Assessment Report Estonian 15-02-2008
Patient Information leaflet Patient Information leaflet Greek 15-02-2008
Summary of Product characteristics Summary of Product characteristics Greek 15-02-2008
Public Assessment Report Public Assessment Report Greek 15-02-2008
Patient Information leaflet Patient Information leaflet English 15-02-2008
Summary of Product characteristics Summary of Product characteristics English 15-02-2008
Public Assessment Report Public Assessment Report English 15-02-2008
Patient Information leaflet Patient Information leaflet French 15-02-2008
Summary of Product characteristics Summary of Product characteristics French 15-02-2008
Public Assessment Report Public Assessment Report French 15-02-2008
Patient Information leaflet Patient Information leaflet Italian 15-02-2008
Summary of Product characteristics Summary of Product characteristics Italian 15-02-2008
Public Assessment Report Public Assessment Report Italian 15-02-2008
Public Assessment Report Public Assessment Report Lithuanian 15-02-2008
Public Assessment Report Public Assessment Report Hungarian 15-02-2008
Patient Information leaflet Patient Information leaflet Dutch 15-02-2008
Summary of Product characteristics Summary of Product characteristics Dutch 15-02-2008
Public Assessment Report Public Assessment Report Dutch 15-02-2008
Public Assessment Report Public Assessment Report Polish 15-02-2008
Patient Information leaflet Patient Information leaflet Portuguese 15-02-2008
Summary of Product characteristics Summary of Product characteristics Portuguese 15-02-2008
Public Assessment Report Public Assessment Report Portuguese 15-02-2008
Public Assessment Report Public Assessment Report Slovak 15-02-2008
Public Assessment Report Public Assessment Report Slovenian 15-02-2008
Patient Information leaflet Patient Information leaflet Finnish 15-02-2008
Summary of Product characteristics Summary of Product characteristics Finnish 15-02-2008
Public Assessment Report Public Assessment Report Finnish 15-02-2008
Patient Information leaflet Patient Information leaflet Swedish 15-02-2008
Summary of Product characteristics Summary of Product characteristics Swedish 15-02-2008
Public Assessment Report Public Assessment Report Swedish 15-02-2008

Search alerts related to this product

Alerts Ultratard cilvēka insulīns insulin human

Ultratard cilvēka insulīns insulin human

View documents history

Documents history Documents history

Ultratard